Articles

Alcon acquires Optinol and enters glaucoma surgical market.

Ophthalmic surgeon Bobby Qureshi is the first in the UK to implant light-adjustable lenses (LALs), which have the capacity to be altered after surgery to provide the best vision for each individual eye without glasses.

Northeastern University engineering professor Jeffrey Ruberti and his research colleagues are breaking new ground in the technique known as "hybrid tissue engineering" by attempting to combine cow tissue with human tissue to produce corneas for human transplant.

Rayner Intraocular Lens Limited, has marked a milestone with a celebration to honour the 60th anniversary of the implantation of the first intraocular lens (IOL) in a patient. The late Sir Harold Ridley implanted the first IOL on 29 November 1949 at St. Thomas Hospital in London. Due to the controversial nature of the surgery, this first surgery was conducted in almost total secrecy.

Fight for Sight has announced £500,000 funding for a new research programme to develop an optimal model of care services for patients with inherited retinal diseases. The five-year programme will be led by Professor Graeme Black, Director of the National Institute for Health Research Manchester Biomedical Research Centre, supported by Professor Tony Moore of Moorfields Eye Hospital and Miss Susie Downes of Oxford Eye Hospital.

Findings published in the European Journal of Ophthalmology have found that intravitreal bevacizumab (IVB) combined with panretinal photocoagulation in patients with open angle neovascular glaucoma (NVG) can reduce iris and angle neovascularization and temporarily inhibit further PAS formation.

In the December issue of the American Journal of Ophthalmology Brandeis University researchers published a paper about the highly precise scleral lens, to treat severe cornea or ocular surface disease, the Boston Ocular Surface Prosthesis (BOS-P).

The Scottish Medicines Consortium (SMC) has announced that Saflutan (tafluprost) has been accepted for restricted use within NHS Scotland for the reduction of elevated intraocular pressure (IOP) in open angle glaucoma and ocular hypertension

Performing surgery in unfamiliar surroundings.

Transconjunctival Muscle Suturing is a new technique that decreases the size of opening by approximately one third.

New model produces results comparable with current glaucoma assessment methods

A proprietary tonometer has been found to be compatible with the Goldmann tonometer in several clinical trials.

Diabetic macular oedema responds to treatment with ranibizumab according to the results of the RESOLVE study.

A doctor's perspective on what influences IOL lens design.

Several manufacturers are developing femtosecond laser technology as a tool for multiple applications in cataract surgery. Three surgeons, who presented at this year's ESCRS Congress look at its uses and results.

Data suggest endothelial stability with Descemet's stripping automated endothelial keratoplasty but is longer-term follow-up needed?

A superior refractive corneal correction can be achieved by the preservation of corneal tissue as well as optimization of ablation profiles that are better adapted to human sight.

A new Tecnis intraocular lens harnesses the ease of implantation of a one-piece implant design and combines it with a glistening-free hydrophobic acrylic material for another next generation IOL.

A comparison study of patients who underwent minimally invasive strabismus surgery (MISS) with a total dissection of the plicated part of the rectus muscle and those who had MISS where only a marginal dissection was performed.

Advanced Cell Technology has filed an Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) to initiate a Phase I/II multicenter study using embryonic-stem-cell-derived retinal cells to treat patients with Stargardt?s Macular Dystrophy (SMD).

The ExciStar XS series from Coherent, Inc. represents a compact, economical excimer laser offering performance and lifetime characteristics.

A study into the process of retinal cell death could hold the key to stopping a variety of eye diseases that cause blindness, according to a report from a team of researchers from the Yale School of Medicine reported in the journal Investigative Ophthalmology & Visual Science.

Poor communication is leading to a high number of mistakes in ophthalmic surgeries, according to a study published in the November issue of Archives of Surgery.

NeoVista has announced that treatment for neovascular AMD using the company?s VIDON ANV Therapy System has begun in Europe. The new system replaces the current course of eye injections with a surgical vitrectomy and a single dose of beta radiation.

Oertli?s new surgical platform Faros, has received its CE mark after meeting EU consumer safety, health or environmental requirements. This important step for the platform keeps it on schedule for an expected March 2010 release.

The IOPtiMate laser-based system, from the Bio-Light Group, used for the non-invasive filtration treatment of glaucoma has received European Patent Office approval.

The NAVILAS laser system, as reported on in the OTE Digest back in May this year ( What is Retinal Navigation? ) has been given FDA approval.

Lumenis is to undertake a clinical study into the efficacy of selective retina therapy (SRT) in diabetic macular oedema (DME).

Ellex Medical Lasers Ltd. unveiled the latest version of its diagnostic ultrasound system (Eye Cubed) at the recent annual meeting of the American Academy of Ophthalmology.

Adrienne Graves, CEO of Santen Inc., has been appointed to the Glaucoma Research Foundation?s board of directors.